Wellbiotec Co., Ltd.
KRX:010600.KS
545 (KRW) • At close April 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 72,132.464 | 190,937.399 | 121,623.325 | 60,431.405 | 83,816.106 | 73,932.352 | 70,785.771 | 85,292.459 | 112,488.077 | 119,630.044 | 137,762.428 | 136,748.153 | 119,782.625 | 86,836.584 | 73,916.511 | 98,179.133 | 112,671.917 |
| Cost of Revenue
| 63,269.011 | 168,150.153 | 111,895.024 | 54,023.73 | 74,782.031 | 70,565.58 | 68,010.352 | 77,391.29 | 101,846.448 | 109,864.004 | 124,346.498 | 121,695.092 | 105,768.693 | 76,524.34 | 62,870.459 | 94,279.461 | 105,882.585 |
| Gross Profit
| 8,863.453 | 22,787.247 | 9,728.3 | 6,407.675 | 9,034.075 | 3,366.772 | 2,775.419 | 7,901.168 | 10,641.629 | 9,766.04 | 13,415.93 | 15,053.061 | 14,013.931 | 10,312.244 | 11,046.052 | 3,899.672 | 6,789.332 |
| Gross Profit Ratio
| 0.123 | 0.119 | 0.08 | 0.106 | 0.108 | 0.046 | 0.039 | 0.093 | 0.095 | 0.082 | 0.097 | 0.11 | 0.117 | 0.119 | 0.149 | 0.04 | 0.06 |
| Reseach & Development Expenses
| 29 | 612.992 | 185.824 | 42.349 | 21.644 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 762.135 | 627.1 | 495.452 | 767.08 |
| General & Administrative Expenses
| 2,327.943 | 1,017.172 | 1,010.285 | 924.574 | 1,849.954 | 2,073.209 | 1,305.547 | 1,556.332 | 1,889.947 | 1,896.919 | 3,648.789 | 3,273.448 | 2,414.868 | 912.383 | 1,089.539 | 1,177.151 | 1,334.252 |
| Selling & Marketing Expenses
| 5,603.43 | 5,357.998 | 3,615.726 | 5,543.154 | 5,009.618 | 2,567.173 | 1,482.365 | 1,430.109 | 1,462.666 | 1,435.954 | 1,592.482 | 1,832.734 | 1,776.705 | 2,315.304 | 2,673.976 | 2,853.93 | 2,365.183 |
| SG&A
| 28,325.588 | 6,375.171 | 4,626.011 | 6,467.727 | 6,859.571 | 4,640.382 | 2,787.912 | 2,986.441 | 3,352.613 | 3,332.873 | 5,241.271 | 5,106.182 | 4,191.573 | 3,227.687 | 3,763.515 | 4,031.081 | 3,699.435 |
| Other Expenses
| -460.242 | 13,239.93 | 8,819.732 | 12,469.707 | 13,547.701 | 222.308 | -2,085.719 | -118.535 | -17.575 | -685.835 | 973.177 | 176.216 | 4,106.441 | -9,298.406 | -2,592.775 | -8,041.009 | -450.988 |
| Operating Expenses
| 28,814.831 | 20,228.092 | 13,631.567 | 18,979.783 | 20,428.917 | 11,817.75 | 7,905.116 | 8,308.059 | 8,565.03 | 9,598.502 | 11,477.52 | 11,835.295 | 8,298.014 | 8,775.226 | 12,435.351 | 11,024.544 | 10,708.04 |
| Operating Income
| -19,951.378 | 5,489.714 | -3,903.266 | -12,572.108 | -11,394.842 | -8,450.977 | -5,129.698 | -406.89 | 2,076.599 | 167.538 | 1,938.411 | 3,217.767 | 3,564.002 | 1,537.021 | -1,389.301 | -7,124.875 | -3,918.705 |
| Operating Income Ratio
| -0.277 | 0.029 | -0.032 | -0.208 | -0.136 | -0.114 | -0.072 | -0.005 | 0.018 | 0.001 | 0.014 | 0.024 | 0.03 | 0.018 | -0.019 | -0.073 | -0.035 |
| Total Other Income Expenses Net
| -44,583.994 | -10,516.933 | -16,985.954 | -38,556.757 | -5,003.699 | -6,015.568 | -3,907.854 | -1,651.378 | -536.964 | -6,255.233 | 1,030.51 | -6,102.885 | -3,311.987 | -13,466.128 | -9,486.66 | -25,870.557 | 803.987 |
| Income Before Tax
| -64,535.372 | -5,027.219 | -20,889.22 | -51,128.865 | -16,398.541 | -14,466.546 | -9,037.551 | -2,058.269 | 1,539.635 | -6,087.695 | 2,968.92 | -2,885.119 | 2,403.93 | -11,929.11 | -10,875.959 | -32,995.429 | -3,114.721 |
| Income Before Tax Ratio
| -0.895 | -0.026 | -0.172 | -0.846 | -0.196 | -0.196 | -0.128 | -0.024 | 0.014 | -0.051 | 0.022 | -0.021 | 0.02 | -0.137 | -0.147 | -0.336 | -0.028 |
| Income Tax Expense
| 516.469 | 1,391.356 | 324.43 | -221.267 | 154.101 | 29.045 | -294.488 | 398.808 | 983.892 | 646.859 | 562.358 | 53.989 | 699.946 | 917.818 | -167.202 | -771.331 | 1,354.853 |
| Net Income
| -64,910.322 | -6,418.575 | -21,213.65 | -50,907.598 | -16,552.641 | -15,565.918 | -8,742.014 | -2,450.152 | 550.244 | -6,655.133 | 2,373.558 | -2,946.007 | 1,581.589 | -12,846.928 | -10,708.758 | -27,664.399 | -6,424.073 |
| Net Income Ratio
| -0.9 | -0.034 | -0.174 | -0.842 | -0.197 | -0.211 | -0.123 | -0.029 | 0.005 | -0.056 | 0.017 | -0.022 | 0.013 | -0.148 | -0.145 | -0.282 | -0.057 |
| EPS
| -819.6 | -99.79 | -383.23 | -1,165.16 | -397.8 | -779.97 | -573 | -161 | 36 | -459.78 | 186 | -242 | 149 | -1,280 | -1,430 | -9,530 | -2,751.55 |
| EPS Diluted
| -819.6 | -99.79 | -383.23 | -1,165.16 | -397.8 | -779.97 | -573 | -161 | 36 | -459.78 | 186 | -242 | 149 | -1,280 | -1,430 | -9,530 | -1,993.64 |
| EBITDA
| -18,478.225 | 6,850.572 | -10,195.466 | -19,850.459 | -2,886.246 | -7,605.499 | -7,833.952 | -1,134.227 | 2,655.969 | 1,134.493 | 5,337.003 | 4,101.486 | 10,135.545 | -5,201.642 | -6,437.343 | -10,145.618 | 1,145.314 |
| EBITDA Ratio
| -0.256 | 0.036 | -0.084 | -0.328 | -0.034 | -0.103 | -0.111 | -0.013 | 0.024 | 0.009 | 0.039 | 0.03 | 0.085 | -0.06 | -0.087 | -0.103 | 0.01 |